Please assess the completion status of the following clinical trial:

Trial Title: Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Hematopoietic progenitor cell transplant subjects with chronic or Grade II-IV acute GVHD being treated with high dose immunosuppressive therapy.~* One of the following to the subject's prior immunosuppressive regimen:~  1. at least 1mg per kg per day of methylprednisolone or equivalent,~ 2. Antithymocyte globulin (ATG) for the therapy of acute GVHD,~ 3. Tacrolimus, mycophenolate mofetil, or other steroid-sparing immunosuppressive regimen.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).